In This Article:
Key Insights
-
Significant control over LTR Pharma by private companies implies that the general public has more power to influence management and governance-related decisions
-
51% of the business is held by the top 9 shareholders
-
Using data from company's past performance alongside ownership research, one can better assess the future performance of a company
A look at the shareholders of LTR Pharma Limited (ASX:LTP) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are private companies with 45% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
Clearly, private companies benefitted the most after the company's market cap rose by AU$60m last week.
Let's delve deeper into each type of owner of LTR Pharma, beginning with the chart below.
See our latest analysis for LTR Pharma
What Does The Institutional Ownership Tell Us About LTR Pharma?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
Less than 5% of LTR Pharma is held by institutional investors. This suggests that some funds have the company in their sights, but many have not yet bought shares in it. So if the company itself can improve over time, we may well see more institutional buyers in the future. When multiple institutional investors want to buy shares, we often see a rising share price. The past revenue trajectory (shown below) can be an indication of future growth, but there are no guarantees.
We note that hedge funds don't have a meaningful investment in LTR Pharma. Looking at our data, we can see that the largest shareholder is LTR medical Pty Ltd with 33% of shares outstanding. Strategic Drug Solutions Inc is the second largest shareholder owning 4.3% of common stock, and Parkview Sc Bio Llc holds about 3.0% of the company stock.
We also observed that the top 9 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
Insider Ownership Of LTR Pharma
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.